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Abstract Bromine K-edge EXAFS studies have been carried
out for bromide/peroxidase samples in Tris buffer at pH 8. The
results are compared with those of aqueous (Tris-buffered)
bromide and vanadium model compounds containing Br-V,
Br-C(aliphatic) and Br-C(aromatic) bonds. It is found that
bromide does not coordinate to the vanadium centre. Rather,
bromine binds covalently to carbon. A possible candidate is active
site serine.
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1. Introduction
Vanadate-dependent peroxidases have been isolated from
sea-weeds such as the brown marine alga Ascophyllum nodo-
sum (AnPO), from a lichen and from the fungus Curvularia
inaequalis (CiPO) [1]. While the CiPO is a chloroperoxidase,
AnPO and other peroxidases from sea-weeds predominantly
are bromo- (and iodo-)peroxidases, which catalyse the two-
electron oxidation of bromide by peroxide to a Br species.
From the thermodynamic point of view, the most likely can-
didate for Br is hypobromous acid, HBrO, which non-enzy-
matically brominates organic substrates or, in the absence of
such substrates, reacts with peroxide to produce singlet oxy-
gen. Many of the halogenated hydrocarbons found in algae
exhibit anti-fungal and anti-bacterial properties. The halogen-
ating activities of the haloperoxidases may thus be related to a
protection mechanism.
The CiPO [2,3] and AnPO [4] have been crystallised and
structurally characterised (Fig. 1). CiPO is a monomer of a
67.5 kDa molecular weight, while AnPO is a homo-dimer,
comprising two ca. 60 kDa subunits containing one vanadate
each. The active site structures (Fig. 1) are practically the
same in the two enzymes, with the exception that Phe-397
in CiPO is replaced by His in AnPO. Vanadium, in its +V
state in the active form, is in a trigonal-bipyramidal environ-
ment, covalently bonded to NO of His-496 and to four oxo/
hydroxo and/or water ligands. The axial OH in the native
form of the CiPO is hydrogen-bonded to His-404, the proto-
nation and deprotonation of which may play an important
role in the mechanisms of bromide oxidation [5,6]. Several
other amino acid side chains (cf. Fig. 1) are involved in a
complex hydrogen bonding network to the vanadate moiety.
Particularly noteworthy in the context of the following dis-
cussion is Ser-402, which is at a distance to the vanadium
centre of 4^5 Aî .
While an X-ray di¡raction analysis [2] and 17O NMR meas-
urements [7] of the peroxo forms of the peroxidases have
revealed direct coordination of peroxide to the vanadium
centre, well in accord with the known ability of V(V) to
form peroxo complexes, information on the binding of bro-
mide to the active centre is scarce. The a⁄nity of AnPO for
Br3 as related to the Michaelis-Menten constant, Km amounts
to 18 mM (pH = 8) [8], but nothing is known about the bind-
ing mode. Although bromovanadium complexes again are
well-established, direct binding of bromide to vanadium is
being considered less probable for this enzyme. In order to
elucidate the question of the nature of bromide binding, we
have now undertaken an EXAFS analysis at the bromine edge
of bromide-enzyme samples of di¡erent Br3 :AnPO ratios,
including aqueous bromide, bovine serum albumin (BSA)
and model compounds with bromine covalently bonded to
vanadium, aromatic or aliphatic carbon. There are a few re-
ports available on XANES studies of AnPO and model com-
pounds [9^12], all carried out at the vanadium K-edge. One of
these studies directed towards substrate binding to the enzyme
supports direct peroxide binding but disfavours bromide bind-
ing to vanadium [10].
2. Materials and methods
AnPO was prepared and puri¢ed as described [13]. The e¡ective
(calculated for M = 60 kDa) ¢nal c(AnPO) was 1.3 mM in all samples.
BSA (fraction V, Merck) was employed as a reference protein due to
its similar molecular weight and isoelectric point. A 26 mM stock
solution of high purity RbBr (Kawecki Berylco Industries) in deion-
ised water and a 0.1 M Tris bu¡er of pH 8.0, prepared from tris(hy-
droxymethyl)aminomethane (Serva) and HCl, were employed in pre-
paring the protein essays. The ¢nal chloride concentrations (due to the
chloride contents of the bu¡er) were 29 mM and hence well below the
concentration where AnPO also exhibits a chloroperoxidase activity
(ca. 1 M [14]). The ratio Cl3/Br3 was about twice that in sea water.
The following samples were investigated: (1) 2.9 mM RbBr in Tris
bu¡er, (2) 22 mM RbBr in Tris, (3) 0.95 mM RbBr+1.3 mM BSA in
Tris, (4a) 1.3 mM RbBr+1.3 mM AnPO in Tris, (4b) 0.8 mM
RbBr+1.3 mM AnPO in Tris, (4c) 0.6 mM RbBr+1.3 mM AnPO in
Tris. The following model compounds (preparative details and char-
acteristics of the model compounds and model reactions will be re-
ported elsewhere) were employed in the form of microcrystalline pow-
ders: trans-(VBr2(mal)2) (mal = maltolate(1-)) (I), VO(CBr3)(OtBu)2
(II) and VO(H2O)(3-Br,5-Cl-sal-gly) (sal-gly is the Schi¡ base from
salicylaldehyde and glycine) (III) (see Scheme 1).
X-ray absorption spectroscopy at the Br K-edge (ca. 13 470 eV) was
carried out at the Hamburger Synchrotonstrahlungslabor (HASY-
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LAB) at the Deutsche Elektronen-Synchroton (DESY), Hamburg,
Germany.
The spectra for the model compounds I, II and III were taken at
beamline X (ROEMO II). The incoming synchrotron beam was
monochromatised by a Si(111) double-crystal monochromator. Ex-
periments were performed in transmission mode at room temperature.
The ground samples, kept under inert gas atmosphere, were put onto
adhesive tape that was wrapped to exclude air as far as possible. Prior
to the experiment, the samples were stored under dry nitrogen. The
EXAFS experiments themselves were carried out in air. For quanti-
tative data evaluation, the program packages AUTOBK and FEFFIT
of the University of Washington were employed [15]. Theoretical
standards were computed with the program FEFF 5.04 [16], using
the crystal structures of the pure compounds as input data. All ¢ts
were carried out with k3-weighted data in R-space. The following ¢t
parameters were used and obtained for the model compounds. I: ¢t
range in k : 2^9.5 Aî , ¢t range in R : 1^5.9 Aî , S20 = 0.56, vE0 = 6.8 eV,
coordination numbers ¢xed to 1, 4 and 1, R(Br-Br) set to R(Br-V). II:
¢t range in k : 2^13 Aî , ¢t range in R : 1^3.4 Aî , S20 = 0.66, vE0 = +6.8
eV, coordination numbers ¢xed to 1, 1 and 2. III: ¢t range in k : 2^11
Aî , ¢t range in R : 1^3.0 Aî , S20 = 1.04, vE0 = +2.9 eV, coordination
numbers ¢xed to 1 and 2. In general, the amplitude reduction factor
S20, the zero-energy shift vE0, the distances R and the Debye-Waller
factors (c2) were allowed to vary in the ¢ts, unless speci¢cally men-
tioned. See also supplementary material, available from the authors
on request, encompasses the un¢ltered k-spectra of samples (1) and
(4c), the experimental spectra superimposed to the model functions
for samples (2), (4a^c) and I^III.
For samples 1^4, spectra were collected at beamline D2 of the
EMBL Hamburg outstation. The liquid samples were injected into
1 mm cuvettes with capton foil windows. Fluorescence-detected
X-ray absorption spectra were measured at 18 K as described else-
where [17]. The energy scale of all collected EXAFS spectra was con-
verted to a k-scale using an E0 of 13 470 eV, k3-weighted spectra were
used for curve-¢tting and calculation of Fourier transforms. For the
Fourier transform shown in Fig. 2, the data corresponding to the
energy range 13 480^13 740 eV were multiplied by a fractional cosine
window (10% cosine fraction at low and high R-side). For curve-¢t-
tings, the energy range was 13 480^13 940 eV. See also supplementary
material, available from the authors on request, encompasses the un-
¢ltered k-spectra of samples (1) and (4c), the experimental spectra
superimposed to the model functions for samples (2), (4a^c) and I^III.
Bromine EXAFS spectra are complicated by multiple excitation
e¡ects [18] which give rise to peaks in the Fourier transforms below
1.2 Aî on the apparent distance scale (see spectrum of aqueous bro-
mide in Fig. 2). The multiple excitation peaks of the aqueous bromide
were extracted by Fourier isolation (window ranging from 0 to 1.5 Aî ,
fractional cosine window with a 2 and 10% cosine fraction at the low
and high R-side, respectively) and subtracted from all four k3-
weighted spectra before curve-¢tting of spectra was approached. For
simulation of k3-weighted spectra, complex backscattering amplitudes
were calculated using the FEFF 7 software [19]. Using the program
SimX (Jens Dittmer, unpublished), the four k3-weighted spectra were
simulated simultaneously (joint-¢t approach) in such a way that cor-
responding bromine-backscatterer distances and Debye-Waller pa-
rameters of the four spectra were ’coupled’ (i.e. constrained to a
common value). In contrast to the coupled bromine-backscatterer
distances (r) and Debye-Waller parameters (ci), the coordination
number parameter (Ni) remained unconstrained (independent varia-
tion of the Ni parameters of all four spectra by the ¢t algorithm). The
obtained Ni values are apparent or relative coordination numbers
which correspond to the product of the ’real’ coordination number
and the relative concentration of either aqueous bromide (for Br-O
and Br-H) or protein-bound bromine (for Br-C and BrWWW(C)-C).
3. Results and discussion
The EXAFS results are collated in Table 1, Fourier trans-
formations of the experimental spectra for the samples (2),
(4a^c) are shown in Fig. 2, those for the model compounds
I, II and III in Fig. 3.
Fig. 1. Schematic representation of the active site of the chloroper-
oxidase CiPO, based on X-ray di¡raction analysis adapted from
[2,3]. In the bromoperoxidase AnPO, Phe-397 is replaced by His [4].
Amino acid residues connected to the protein pocket by dashes are
in direct hydrogen bonding interaction with the oxovanadate(V)
centre.
Table 1
EXAFS parametersa
Sampleb Assignment N r/Aî c2/Aî 2U103
(2)c Br3 22 mM Br-(H)-O 4.9 3.23 25
Br-H(-O) 4.9d 2.38 9
(4)c Br3 0.6^1.3 mM+AnPO 1.3 mM Br-C 1.03e 1.88 1d
Br-(C)-C 1.09e 2.89 1d
I Br-V 1d 2.39 5.2
Br-(V)-O 4d 3.15 16.6
Br-(V)-Br 1d 4.79f 22.4
II Br-Caliph 1d 1.97 2.8
Br-(C)-V 1d 3.40 8.7
Br-(C)-Br 2d 3.16 5.1
III Br-Carom 1d 1.89 2.5
Br-(C)-C 2d 2.84 6.8
aCoordination number N, e¡ective distance r and Debye-Waller factor c2.
bFor sample assignments, see also Section 2 and Scheme 1.
cCurve-¢t results from a joint-¢t of the samples (2) and (4a^c) (cf. Section 2).
dFixed parameters.
eObtained from an extrapolation of Nrel to d =31.94, where d is the normalised di¡erence between bromide and enzyme concentrations, see
text.
f Fixed to 2r(Br-V).
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EXAFS features characteristic of the hydration sphere of
bromide and its possible interaction with the Tris bu¡er have
been obtained for aqueous RbBr solutions at low concentra-
tions (2.9 and 22 mM) in 0.1 M Tris bu¡er of pH 8.0. The
main peak in the Fourier-transformed spectrum (cf. Fig. 2,
dotted line) at an e¡ective distance of 3.23 Aî can be inter-
preted in terms of an oxygen shell and compares with distan-
ces previously reported for the BrWWWO of the hydration shell of
bromide in concentrations of 1 M up to saturation [20,20].
The BrWWWO coordination number found in our study, 4.9, ex-
ceeds that in previous reports (average of ca. 2.6 in 1 M
solutions [20]). These di¡erences may be due to a more pro-
nounced hydration at lower concentrations or due to the par-
ticipation of alcoholic functions of the bu¡er in outer sphere
coordination. Apart from the BrWWWO peak, there is a distinct
feature at 2.38 Aî , which was successfully modelled by ¢ve
hydrogens and which we therefore tentatively assign to hydro-
gens in hydrogen bonding contact with bromide. Additional
characteristics in the spectra are assigned to photoelectron
backscattering at the bromide electron shell (1.0 Aî [22]), dou-
ble-electron excitations [18,23] and higher solvation spheres.
In order to minimise the possibility that EXAFS patterns in
the enzyme-bromide samples are due to unspeci¢c bromide
binding to the protein, we have also measured a sample con-
taining BSA and bromide under the same concentration and
pH conditions (cf. sample (3) in Section 2) as with the enzyme
samples. No di¡erences between bromide solutions with and
without the serum albumin were detected.
EXAFS spectra of AnPO+bromide in Tris bu¡er (samples
4a^c) were obtained for the concentration ratios 1.3/1.3, 1.3/
0.8 and 1.3/0.6 mM. The Fourier transformations have been
included in Fig. 2, the experimental spectra are provided in
the supplementary material. For EXAFS parameters, cf. Ta-
ble 1. With a decreasing bromide concentration (increasing
the ratio c(enzyme)/c(bromide)), the peak due to the hydra-
tion shell loses intensity. Concomitantly, a peak arises at an
e¡ective distance of 1.88 Aî . Comparison with bond parame-
ters from di¡raction studies and with the model compounds
I^III (Fig. 3) excludes coordination of the bromide to vana-
dium and suggests covalent binding to a light atom, the clos-
est candidate being an sp2-hybridised (e.g. aromatic) carbon.
The covalent character of the bond is also revealed by the
position of the K-edge, which moves to higher energies as
hydrated bromide is increasingly replaced by active site-bound
bromine. Hence, our results indicate that an organic residue is
Scheme 1.
Fig. 2. Fourier transformations of samples (2) (22 mM bromide,
dotted line) and (4a^c) (1.3/0.8/0.6 mM bromide+1.3 mM AnPO,
broken and solid lines).
Fig. 3. Fourier transformations of model samples I (V-Br bond), II
(V-Caliphat bond) and III (V-Carom bond). See Scheme 1 for the
model compounds. The solid lines represent experimental spectra,
dotted lines represent model functions.
Fig. 4. Plot of the normalised concentration of free bromide, [Br3]/
c(Br3), versus the normalised di¡erence (d) of the concentrations of
overall bromide and enzyme. [Br3]/c(Br3) is related to the relative
coordination number Nrel for the hydration shell of free bromide by
[Br3]/c(Br3) = Nrel/4.9.
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brominated. Assignment of the 1.88 Aî feature to the Br-Carom
bond (a possible candidate is the imidazole of a histidine),
however, requires an electrophilic attack, i.e. a Br species,
the generation of which in the assay used is unlikely to occur.
A candidate for nucleophilic substitution, on the other hand,
is the active site serine. EXAFS distances Br-Caliph of bro-
moalkanes [23,23] and bromoacetates [22,25,26] range from
1.93 to 1.96 Aî . A search for Br-C bond lengths of Br-C bonds
in the vicinity (L position) of an amide bond revealed 1.94 Aî
as an average value (the range is 1.87^1.99 Aî ). Geometry-
optimised simulation of the distances Br-CL and BrWWWCK in
the serinyl residue with HyperChem a¡ords 1.91 and 2.82
Aî , respectively. Hence, although from a chemical point of
view, bromination of serine, possibly by a short-lived bromo-
vanadium(V) intermediate (in vitro studies have shown that
the methyl ester of serine is brominated by VOBr3 and type I
complexes (cf. Scheme I) in acetonitrile), is a reasonable as-
sumption, the short EXAFS parameter of 1.88 Aî is not fully
explained on such a basis. If serine is the site of bromination,
one would expect, according to the X-ray di¡raction results
on CiPO and AnPO, the metal centre at a distance of 4^5 Aî .
Fig. 2 shows a feature at about this distance. At the present
stage of experimental evidence, an unambiguous assignment
can, however, not be carried out.
We have ¢nally evaluated the EXAFS results with respect
to the extent of saturation of the bromine binding site, using
Br-C and Br-O coordination numbers. The overall bromide
concentration c0(Br3) in the bromide-enzyme samples is dis-
tributed between the equilibrium concentrations of free bro-
mide, [Br3], and enzyme-bound bromide. If the normalised
equilibrium concentration of free bromide, [Br3]/c(Br3), is
plotted against d = (c(Br3)3c(enzyme))/c(Br3), the normalised
di¡erence between the concentrations of bromide and enzyme,
a linear relation is obtained (Fig. 4). The intercept with the d
axis at 31.94 corresponds to c(Br3) = 0.44 mM, the situation
where all of the bromide is bound to the enzyme (c(en-
zyme) = 1.3 mM). The linear regression is indicative of a
high a⁄nity of the enzyme for the bromide. The concentra-
tion-dependence, however, implies that a maximum of 40% of
the enzyme actually binds bromine covalently. There are sev-
eral reasons for this de¢ciency. For one thing, the vanadium
contents may be less than one vanadate per enzyme subunit
(or part of the vanadium is bound unspeci¢cally). For another
thing, admixtures of iodide, which competes with bromide for
the binding site, may be present. We have earlier provided
evidence for the presence of up to 0.5 mol iodine per mol
enzyme [27] and also for the unspeci¢c binding of vanadate
[28].
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